COVID-19 reinfection: the role of natural immunity, vaccines, and variants

The COVID-19 pandemic has altered innumerable lives. Although recent mass vaccinations offer a glimmer of hope, the rising death toll and new variants continue to dominate the current scenario. As we begin to understand more about SARS-CoV-2 infections, the territory of reinfections with COVID-19 re...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Bao Y. Sciscent, Caroline D. Eisele, Lisa Ho, Steven D. King, Rohit Jain, Reshma R. Golamari
Formato:	article
Lenguaje:	EN
Publicado:	Taylor & Francis Group 2021
Materias:	covid-19 reinfection covid-19 vaccination covid-19 immunity sars-cov-2 Internal medicine RC31-1245
Acceso en línea:	https://doaj.org/article/3ce28781f82641e39bb93308b4561136
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:3ce28781f82641e39bb93308b4561136
record_format	dspace
spelling	oai:doaj.org-article:3ce28781f82641e39bb93308b45611362021-11-17T14:21:57ZCOVID-19 reinfection: the role of natural immunity, vaccines, and variants2000-966610.1080/20009666.2021.1974665https://doaj.org/article/3ce28781f82641e39bb93308b45611362021-11-01T00:00:00Zhttp://dx.doi.org/10.1080/20009666.2021.1974665https://doaj.org/toc/2000-9666The COVID-19 pandemic has altered innumerable lives. Although recent mass vaccinations offer a glimmer of hope, the rising death toll and new variants continue to dominate the current scenario. As we begin to understand more about SARS-CoV-2 infections, the territory of reinfections with COVID-19 remains unexplored. In this review, we will discuss several aspects of reinfection: (a) How is COVID-19 reinfection characterized? (b) Does prior literature differentiate between reinfection and reactivation? (c) What SARS-CoV-2 strains do the vaccines target and can they protect against new strains? Larger and longer timeline studies are needed to understand reinfection risks. With the ongoing distribution of the SARS-CoV-2 vaccines to provide protection, the understanding of the possibility for SARS-CoV-2 reinfection remains critical. Abbreviations CDC: Centers for Disease ControlSARS-CoV-2: Severe acute respiratory syndrome coronavirus 2COVID-19: Coronavirus disease 2019RT-PCR: Reverse Transcription Polymerase Chain ReactionPASC: Post-Acute Sequelae of SARS-CoV-2 infectionBao Y. SciscentCaroline D. EiseleLisa HoSteven D. KingRohit JainReshma R. GolamariTaylor & Francis Grouparticlecovid-19reinfectioncovid-19 vaccinationcovid-19 immunitysars-cov-2Internal medicineRC31-1245ENJournal of Community Hospital Internal Medicine Perspectives, Vol 11, Iss 6, Pp 733-739 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	covid-19 reinfection covid-19 vaccination covid-19 immunity sars-cov-2 Internal medicine RC31-1245
spellingShingle	covid-19 reinfection covid-19 vaccination covid-19 immunity sars-cov-2 Internal medicine RC31-1245 Bao Y. Sciscent Caroline D. Eisele Lisa Ho Steven D. King Rohit Jain Reshma R. Golamari COVID-19 reinfection: the role of natural immunity, vaccines, and variants
description	The COVID-19 pandemic has altered innumerable lives. Although recent mass vaccinations offer a glimmer of hope, the rising death toll and new variants continue to dominate the current scenario. As we begin to understand more about SARS-CoV-2 infections, the territory of reinfections with COVID-19 remains unexplored. In this review, we will discuss several aspects of reinfection: (a) How is COVID-19 reinfection characterized? (b) Does prior literature differentiate between reinfection and reactivation? (c) What SARS-CoV-2 strains do the vaccines target and can they protect against new strains? Larger and longer timeline studies are needed to understand reinfection risks. With the ongoing distribution of the SARS-CoV-2 vaccines to provide protection, the understanding of the possibility for SARS-CoV-2 reinfection remains critical. Abbreviations CDC: Centers for Disease ControlSARS-CoV-2: Severe acute respiratory syndrome coronavirus 2COVID-19: Coronavirus disease 2019RT-PCR: Reverse Transcription Polymerase Chain ReactionPASC: Post-Acute Sequelae of SARS-CoV-2 infection
format	article
author	Bao Y. Sciscent Caroline D. Eisele Lisa Ho Steven D. King Rohit Jain Reshma R. Golamari
author_facet	Bao Y. Sciscent Caroline D. Eisele Lisa Ho Steven D. King Rohit Jain Reshma R. Golamari
author_sort	Bao Y. Sciscent
title	COVID-19 reinfection: the role of natural immunity, vaccines, and variants
title_short	COVID-19 reinfection: the role of natural immunity, vaccines, and variants
title_full	COVID-19 reinfection: the role of natural immunity, vaccines, and variants
title_fullStr	COVID-19 reinfection: the role of natural immunity, vaccines, and variants
title_full_unstemmed	COVID-19 reinfection: the role of natural immunity, vaccines, and variants
title_sort	covid-19 reinfection: the role of natural immunity, vaccines, and variants
publisher	Taylor & Francis Group
publishDate	2021
url	https://doaj.org/article/3ce28781f82641e39bb93308b4561136
work_keys_str_mv	AT baoysciscent covid19reinfectiontheroleofnaturalimmunityvaccinesandvariants AT carolinedeisele covid19reinfectiontheroleofnaturalimmunityvaccinesandvariants AT lisaho covid19reinfectiontheroleofnaturalimmunityvaccinesandvariants AT stevendking covid19reinfectiontheroleofnaturalimmunityvaccinesandvariants AT rohitjain covid19reinfectiontheroleofnaturalimmunityvaccinesandvariants AT reshmargolamari covid19reinfectiontheroleofnaturalimmunityvaccinesandvariants
_version_	1718425475336896512

COVID-19 reinfection: the role of natural immunity, vaccines, and variants

Ejemplares similares